Hyperalgesia

Hyperalgesia
ICD-9	782.0
DiseasesDB	30788
MeSH	D006930

WikiDoc Resources for Hyperalgesia
Articles
Most recent articles on Hyperalgesia Most cited articles on Hyperalgesia Review articles on Hyperalgesia Articles on Hyperalgesia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Hyperalgesia Images of Hyperalgesia Photos of Hyperalgesia Podcasts & MP3s on Hyperalgesia Videos on Hyperalgesia
Evidence Based Medicine
Cochrane Collaboration on Hyperalgesia Bandolier on Hyperalgesia TRIP on Hyperalgesia
Clinical Trials
Ongoing Trials on Hyperalgesia at Clinical Trials.gov Trial results on Hyperalgesia Clinical Trials on Hyperalgesia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Hyperalgesia NICE Guidance on Hyperalgesia NHS PRODIGY Guidance FDA on Hyperalgesia CDC on Hyperalgesia
Books
Books on Hyperalgesia
News
Hyperalgesia in the news Be alerted to news on Hyperalgesia News trends on Hyperalgesia
Commentary
Blogs on Hyperalgesia
Definitions
Definitions of Hyperalgesia
Patient Resources / Community
Patient resources on Hyperalgesia Discussion groups on Hyperalgesia Patient Handouts on Hyperalgesia Directions to Hospitals Treating Hyperalgesia Risk calculators and risk factors for Hyperalgesia
Healthcare Provider Resources
Symptoms of Hyperalgesia Causes & Risk Factors for Hyperalgesia Diagnostic studies for Hyperalgesia Treatment of Hyperalgesia
Continuing Medical Education (CME)
CME Programs on Hyperalgesia
International
Hyperalgesia en Espanol Hyperalgesia en Francais
Business
Hyperalgesia in the Marketplace Patents on Hyperalgesia
Experimental / Informatics
List of terms related to Hyperalgesia

Hyperalgesia is an extreme sensitivity to pain, which in one form is caused by damage to nociceptors in the body's soft tissues.

Hyperalgesia can be experienced in focal, discrete areas, or as a more diffuse, body-wide form. Conditioning studies have established that it is possible to experience a learned hyperalgesia of the latter, diffuse form. The focal form is typically associated with injury, and is divided into two subtypes:

• Primary hyperalgesia describes pain sensitivity that occurs directly in the damaged tissues.
• Secondary hyperalgesia describes pain sensitivity that occurs in surrounding undamaged tissues.

Hyperalgesia is induced by Platelet Aggregating Factor (PAF) which comes about in an inflammatory or an allergic response. This seems to occur via immune cells interacting with the peripheral nervous system and releasing pain-producing chemicals (cytokines and chemokines) (see Marchand, Perretti, & McMahon, 2005).

One unusual cause of focal hyperalgesia is platypus venom.

Ikeda, Stark, Fischer, Wagner, Drdla, Jäger, et al. (2006) showed that stimulation of pain fibres in a pattern consistent with that from inflammation switched on a form of amplification in the spinal cord, long term potentiation. This occurred where the pain fibres contacted a pain pathway, the periaqueductal grey. Ikeda et al. argued that amplification in the spinal cord is another way of producing hyperalgesia.

References

• Ikeda, H., Stark, J., Fischer, H., Wagner, M., Drdla, R., Jäger, T., et al. (2006). Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science, 312, 1659-1662.
• Marchand, F., Perretti, M., & McMahon, S. B. (2005). Role of the immune system in chronic pain. Nature Reviews Neuroscience, 6, 521-532.

External links

• Hypoalgesia